Literature DB >> 8908421

Diagnosis in adolescent inpatients: diagnostic confidence and comparison of diagnoses using ICD-9 and DSM-III.

R J McCabe1, D J Rothery, R M Wrate, J Aspin, J G Bryce.   

Abstract

In a prospective Multi-Centre research study involving four British Adolescent Psychiatry Inpatient Units, all 276 adolescent admissions were diagnosed using both ICD-9 and DSM-III. Ratings of diagnostic confidence for each diagnostic group varied considerably. Clinicians recorded high levels of confidence in the diagnosis of both Schizophrenia and Anorexia nervosa, while considerably lower scores were noted for Adjustment Disorders (ICD-9 3-digit code 309.), and for Emotional Disorders (ICD-9 3-digit code 313.). Exact concordance in diagnoses made for each case using both ICD-9 and DSM-III occurred in 72% of the entire cohort. The dissimilar concordance rates comparing ICD-9 and DSM-III diagnoses for the same patient admissions suggest differences in validity measures, such as face validity and content validity, in the reliability of diagnostic criteria between similarly named disorders across the two systems, and in the clinician's training and attitude to diagnosis. With the recent introduction of DSM-IV following upon ICD-10, further comparative studies are needed to examine both reliability and validity issues into diagnosis and classification in child and adolescent psychiatry.

Entities:  

Mesh:

Year:  1996        PMID: 8908421     DOI: 10.1007/bf00571674

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  13 in total

Review 1.  Issues in the classification of child and adolescent psychopathology.

Authors:  D P Cantwell; L Baker
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1988-09       Impact factor: 8.829

2.  Phenomenal and operationalized classification of psychiatric disorders in children and adolescents with ICD-9 and ICD-10, on the basis of a field study.

Authors:  B Blanz; M H Schmidt; J Niemeyer; H Amorosa
Journal:  Pharmacopsychiatry       Date:  1990-06       Impact factor: 5.788

3.  Child psychiatric disorders in ICD-10.

Authors:  M Rutter
Journal:  J Child Psychol Psychiatry       Date:  1989-07       Impact factor: 8.982

4.  Perceived suitability and usefulness of DSM-III vs. DSM-II in child psychopathology.

Authors:  A C Mezzich; J E Mezzich
Journal:  J Am Acad Child Psychiatry       Date:  1985-05

5.  [Classification of psychiatric disorders in children: a comparison of the most frequent systems].

Authors:  J L Pedreira Massa; F Rincón Palomino
Journal:  Actas Luso Esp Neurol Psiquiatr Cienc Afines       Date:  1989 Nov-Dec

6.  Treatment goal-planning: outcome findings of a British prospective multi-centre study of adolescent inpatient units.

Authors:  D Rothery; R Wrate; R McCabe; J Aspin; G Bryce
Journal:  Eur Child Adolesc Psychiatry       Date:  1995-07       Impact factor: 4.785

7.  The diagnosis of childhood hyperactivity. A U.S.-U.K. cross-national study of DSM-III and ICD-9.

Authors:  M Prendergast; E Taylor; J L Rapoport; J Bartko; M Donnelly; A Zametkin; M B Ahearn; G Dunn; H M Wieselberg
Journal:  J Child Psychol Psychiatry       Date:  1988-05       Impact factor: 8.982

Review 8.  Child psychiatric disorders: are they classifiable?

Authors:  J S Werry
Journal:  Br J Psychiatry       Date:  1992-10       Impact factor: 9.319

9.  [Child and adolescent psychiatric classification in an unselected sample--a comparison of MAS and DSM-III].

Authors:  B Blanz; M H Schmidt
Journal:  Z Kinder Jugendpsychiatr       Date:  1986

10.  A comparison of ICD-9 and ICD-10 diagnoses of child and adolescent psychiatric disorders.

Authors:  H C Steinhausen; A Erdin
Journal:  J Child Psychol Psychiatry       Date:  1991-09       Impact factor: 8.982

View more
  1 in total

1.  [Schizophrenia in children and adolescents. An investigation of 305 consecutive inpatient treatment cases].

Authors:  H Remschmidt; K Wolf-Ostermann; F Mattejat
Journal:  Nervenarzt       Date:  2004-07       Impact factor: 1.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.